<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0871-9721</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Imunoalergologia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Port Imunoalergologia]]></abbrev-journal-title>
<issn>0871-9721</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Alergologia e Imunologia Clínica]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0871-97212021000100038</article-id>
<article-id pub-id-type="doi">10.32932/rpia.2021.03.052</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Qualidade de vida em crianças e adolescentes com dermatite atópica e seus cuidadores]]></article-title>
<article-title xml:lang="en"><![CDATA[Quality of life in children and adolescents with atopic dermatitis and their caregivers]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[Priscilla]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Dias]]></surname>
<given-names><![CDATA[Gabriela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Clair Junior]]></surname>
<given-names><![CDATA[Saint]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cerqueira]]></surname>
<given-names><![CDATA[Ana Maria]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Municipal Jesus  ]]></institution>
<addr-line><![CDATA[Rio de Janeiro ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidade do Estado do Rio de Janeiro  ]]></institution>
<addr-line><![CDATA[Rio de Janeiro ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Fernandes Figueiras  ]]></institution>
<addr-line><![CDATA[Rio de Janeiro ]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2021</year>
</pub-date>
<volume>29</volume>
<numero>1</numero>
<fpage>38</fpage>
<lpage>48</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S0871-97212021000100038&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S0871-97212021000100038&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S0871-97212021000100038&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução: A dermatite atópica (DA) é uma doença inflamatória crônica e a avaliação da qualidade de vida e da gravidade da doença é importante para auxiliar a abordagem clínica e a terapêutica.  Objetivo: Avaliar o impacto na qualidade de vida da DA em crianças e adolescentes e seus cuidadores e correlacionar com a gravidade da doença.  Materiais e métodos: Estudo transversal, com avaliação de características sócio-demográficas e aplicação de questionários nos cuidadores e pacientes pediátricos com DA consultados entre março a maio de 2018, em ambulatório de dermatologia. A gravidade foi avaliada conforme o Scoring Atopic Dermatitis (SCORAD) e classificada como leve, moderada ou grave. O Dermatitis Family Impact Questionnaire (DFI) e o Children's Dermatology Life Quality Index (CDLQI) foram utilizados para avaliação da qualidade de vida.  Resultados: Foram avaliados 34 pacientes com DA entre 4 e 15 anos. A média do SCORAD foi 29,14 (DP ± 14,85) sendo 32% leve, 44% moderada e 24% grave. A média do CDLQI foi 7,32 (DP ± 5,91) e do DFI de 12,62 (DP ± 7,34). O domínio mais comprometido no DFI foi o impacto global na vida do cuidador, seguido pelas despesas com tratamento. Na avaliação do CDLQI, os itens com os piores índices foram o prurido e alteração do sono. Observou-se diferença significativa na qualidade de vida dos pacientes (p = 0,01) e cuidadores (p = 0,005) entre os pacientes com DA leve e grave, que não foi encontrada entre aqueles com DA leve e moderada e entre moderada e grave. Os índices de qualidade de vida dos cuidadores (&#961; = 0,62; p &lt; 0,0001) e dos pacientes (&#961; = 0,53; p = 0,001) mostraram uma correlação positiva e moderada com o SCORAD e entre si (&#961; = 0,64; p &lt; 0,0001).  Conclusão: A DA interfere negativamente na qualidade de vida dos pacientes e de seus familiares, sendo os piores índices relacionados à maior gravidade da doença.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: Atopic dermatitis (AD) is a chronic inflammatory disease and the assessment of the quality of life and the severity of the disease is important to help the clinical and therapeutic approach.  Objective: To assess the impact of AD on the quality of life of patients and caregivers and correlate with the severity of the disease.  Material and Methods:  Cross-sectional study, with assessment of socio-demographic characteristics and application of questionnaires in caregivers and pediatric patients with AD observed between March and May 2018, in a dermatology clinic. Severity was assessed according to the Scoring Atopic Dermatitis (SCORAD) and classified as mild, moderate or severe. The Dermatitis Family Impact Questionnaire (DFI) and the Children`s Dermatology Life Quality Index (CDLQI) were used to assess quality of life.  Results: Thirty-four patients with AD between 4 and 15 years old were evaluated. The SCORAD mean was 29.14 (SD ± 14.85), 32% mild, 44% moderate and 24% severe. The CDLQI mean was 7.32 (SD ± 5.91) and the DFI was 12.62 (SD ± 7.34). The most compromised domain in the DFI was the global impact on the caregiver´s life, followed by treatment expenses. In the CDLQI evaluation, the items with the worst indexes were itching and sleep disorders. There was a significant difference in the quality of life of patients (p = 0.01) and caregivers (p = 0.005) between patients with mild and severe AD, which was not found between moderate and severe AD. The quality of life indexes of caregivers (&#961; = 0.62; p &lt;0.0001) and patients (&#961;= 0.53; p = 0.001) showed a positive and moderate correlation with SCORAD and with each other (&#961; = 0.64; p &lt; 0.0001).  Conclusion: AD interferes negatively in the quality of life of patients and their families, with the worst rates related to the greater severity of the disease.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Adolescentes]]></kwd>
<kwd lng="pt"><![CDATA[crianças]]></kwd>
<kwd lng="pt"><![CDATA[dermatite atópica]]></kwd>
<kwd lng="pt"><![CDATA[qualidade de vida.]]></kwd>
<kwd lng="en"><![CDATA[Adolescents]]></kwd>
<kwd lng="en"><![CDATA[atopic dermatitis]]></kwd>
<kwd lng="en"><![CDATA[children]]></kwd>
<kwd lng="en"><![CDATA[quality of life]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avena-Woods]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Overview of atopic dermatitis]]></article-title>
<source><![CDATA[Am J Manag Care]]></source>
<year>2017</year>
<volume>23</volume>
<numero>^s8</numero>
<issue>^s8</issue>
<supplement>8</supplement>
<page-range>S115-23</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nutten]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atopic dermatitis: global epidemiology and risk factors]]></article-title>
<source><![CDATA[Ann Nutr Metab]]></source>
<year>2015</year>
<volume>66</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>8-16</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kemp]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cost of Illness of Atopic Dermatitis in Children]]></article-title>
<source><![CDATA[PharmacoEconomics]]></source>
<year>2003</year>
<volume>21</volume>
<page-range>105-13</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fennessy]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Coupland]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Popay]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Naysmith]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research]]></article-title>
<source><![CDATA[J Epidemiol Community Health]]></source>
<year>2000</year>
<volume>54</volume>
<page-range>581-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Seo]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Jo]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Yim]]></surname>
<given-names><![CDATA[HW]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of life and disease severity are correlated in patients with atopic dermatitis]]></article-title>
<source><![CDATA[J Korean Med Sci]]></source>
<year>2012</year>
<volume>27</volume>
<page-range>1327-32</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prati]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Comparin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Catucci Boza]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira Cestari]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validação para o português falado no Brasil do instrumento Escore da Qualidade de Vida na Dermatologia Infantil (CDLQI)]]></article-title>
<source><![CDATA[Med Cutan Iber Lat Am]]></source>
<year>2010</year>
<volume>38</volume>
<page-range>229-33</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hanifin]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Rajka]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic features of atopic dermatitis]]></article-title>
<source><![CDATA[Acta Derm Venereol]]></source>
<year>1980</year>
<volume>92</volume>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis]]></article-title>
<source><![CDATA[Dermatology]]></source>
<year>1997</year>
<volume>195</volume>
<page-range>10-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Antunes]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Solé]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[VO]]></given-names>
</name>
<name>
<surname><![CDATA[Bau]]></surname>
<given-names><![CDATA[AEK]]></given-names>
</name>
<name>
<surname><![CDATA[Kuschnir]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
<name>
<surname><![CDATA[Mallozi]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guia prático de atualização em dermatite atópica - Parte I: etiopatogenia, clínica e diagnóstico. Posicionamento conjunto da Associação Brasileira de Alergia e Imunologia e da Sociedade Brasileira de Pediatria]]></article-title>
<source><![CDATA[Arq Asma Alerg Imunol]]></source>
<year>2017</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>131-57</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancini]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kaulback]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Chamlin]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The socioeconomic impact of atopic dermatitis in the United States: a systematic review]]></article-title>
<source><![CDATA[Pediatr Dermatol]]></source>
<year>2008</year>
<volume>25</volume>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Fonseca]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Matias-Dias]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rede Médicos-Sentinela como Instrumento de Vigilância em Saúde ENT#091;PúblicaENT#093;]]></article-title>
<source><![CDATA[Acta Med Port]]></source>
<year>2016</year>
<volume>29</volume>
<page-range>5-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cheng]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[XY]]></given-names>
</name>
<name>
<surname><![CDATA[He]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of Quality of Life of Children With Atopic Dermatitis Before and After Treatment]]></article-title>
<source><![CDATA[Chinise J Contemp Pediatrics]]></source>
<year>2017</year>
<volume>19</volume>
<page-range>682-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alvarenga]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Caldeira]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of life in pediatric patients with atopic dermatitis]]></article-title>
<source><![CDATA[J Pediatr]]></source>
<year>2009</year>
<volume>85</volume>
<page-range>415-20</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[SLC]]></given-names>
</name>
<name>
<surname><![CDATA[Boguchewski]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Nascimento]]></surname>
<given-names><![CDATA[FLS]]></given-names>
</name>
<name>
<surname><![CDATA[Dalmas]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[VO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impacto da dermatite atópica na qualidade de vida da família]]></article-title>
<source><![CDATA[Braz J Allergy Immunol]]></source>
<year>2017</year>
<volume>1</volume>
<page-range>305-10</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[EO]]></given-names>
</name>
<name>
<surname><![CDATA[Gonçalo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mendes-Bastos]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Selores]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Filipe]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Update on Atopic Dermatitis]]></article-title>
<source><![CDATA[Acta Med Port]]></source>
<year>2019</year>
<volume>32</volume>
<page-range>606-13</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Aguiar]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mendes-Bastos]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Palma-Carlos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrinho]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of Life and characterization of patients with atopic dermatitis in Portugal - QUADEP study]]></article-title>
<source><![CDATA[J Investig Allergol Clin Immunol]]></source>
<year>2020</year>
<volume>30</volume>
<page-range>430-8</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bezerra]]></surname>
<given-names><![CDATA[ALC]]></given-names>
</name>
<name>
<surname><![CDATA[Araújo]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[MAL]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[AAS]]></given-names>
</name>
<name>
<surname><![CDATA[Pires Carla]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of atopic dermatitis on the quality of life of pediatric patients and their guardians]]></article-title>
<source><![CDATA[Rev Paul Pediatr]]></source>
<year>2017</year>
<volume>35</volume>
<page-range>5-10</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Su]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Kemp]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Varigos]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Nolam]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atopic eczema: its impact on the family and financial cost]]></article-title>
<source><![CDATA[Arch Dis Child]]></source>
<year>1997</year>
<volume>76</volume>
<page-range>159-62</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marciniak]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Reich]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Szepietowski]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of Life of Parents of Children with Atopic Dermatitis]]></article-title>
<source><![CDATA[Acta Derm Venereol]]></source>
<year>2017</year>
<volume>97</volume>
<page-range>711-4</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dahl]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Bernhisel-Broadbent]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Scanlon-Holdford]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sampson]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Lupo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sleep disturbances in children with atopic dermatitis]]></article-title>
<source><![CDATA[Arch Pediatr Adolesc Med]]></source>
<year>1995</year>
<volume>149</volume>
<page-range>856-60</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ben-Gashir]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Seed PT]]></surname>
<given-names><![CDATA[Hay RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A qualidade de vida familiar ea gravidade da doença estão relacionadas à dermatite atópica infantil?]]></article-title>
<source><![CDATA[J Eur Acad Dermatol Venereol]]></source>
<year>2002</year>
<volume>16</volume>
<page-range>455-62</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
